Moffitt, AstraZeneca partner on cell therapy development

Moffitt Cancer Center and AstraZeneca are partnering to accelerate the development of CAR-T cell and T cell receptor therapies. The collaboration will advance clinical studies of cell therapies in solid tumors, with the aim of bringing potential new cell therapies to patients faster and more efficiently.